WTF is with Nikhil Kamath cover image

Ep #7 | Who is Kiran Mazumdar Shaw Really? And WTF is Biotech?

WTF is with Nikhil Kamath

CHAPTER

Biopharmaceuticals: The Future of Enzymes

Biocon went public in 2000 after pivoting from enzymes to biopharmaceuticals. The company now makes statins using fungal fermentation technologies. AIG calls Biocon's IPO "the best investment they've ever made to date"

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner